DRUG NEWS: FDA moves to control label changes

$3.95
Nursing2014
May 2005 
Volume 35  Number 5
Pages 30 - 30
 
  PDF Version Available!

ABSTRACT
© 2005 Lippincott Williams & Wilkins, Inc. Volume 35(5)             May 2005             p 30 FDA moves to control label changes [DRUG NEWS: ADVERSE DRUG REACTIONS]

The FDA petitioned Congress for the authority to dictate drug label changes. Currently, the FDA has to negotiate with drug companies about changes, which can delay warnings to the public.

At a congressional committee hearing, Sandra L. Kweder, FDA deputy director for new drugs, testified that a public warning about the dangers of rofecoxib (Vioxx) was delayed because the FDA had to haggle with the drug's manufacturer, Merck & Co., about the language. Merck pulled Vioxx from the market in September because some patients taking the drug developed serious cardiac problems.

Under a new policy, the Bush administration has endorsed announcing warnings to the public before label changes are finalized. Congress is also considering ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events